查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球人工呼吸器性别、类型、介面、模式和护理环境划分 - 预测至 2029 年
市场调查报告书
商品编码
1667627

全球人工呼吸器性别、类型、介面、模式和护理环境划分 - 预测至 2029 年

Ventilators Market by Mobility (Intensive Care Ventilators, Transportable Ventilators), Type (Adult & Pediatric Ventilators), Interface (Hybrid Ventilation), Mode (Combined Mode Ventilation), Care Setting (Hospitals & Clinics) - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 292 Pages | 订单完成后即时交付

价格

全球人工呼吸器市场规模预计将从 2024 年的 37.1 亿美元增至 2029 年的 46.6 亿美元，预测期内的复合年增长率为 4.7%。

研究范围
调查年份 2021-2029
基准年 2023
预测期 2024-2029
单元 美元
部分 类型、年龄层、介面、方式、护理环境、区域
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲、海湾合作委员会国家

慢性阻塞性肺病和气喘等呼吸系统疾病的增加是人工呼吸器市场的主要驱动力。空气污染水平的上升、生活方式的改变和人口老化导致这些慢性疾病的增加以及呼吸道疾病发作的频率和严重程度的增加。患有慢性阻塞性肺病和严重气喘的患者在病情急性发作期间经常需要呼吸支持，这增加了医院和居家照护对有创和非侵入性人工呼吸器机的需求。此外，人工呼吸器技术的不断进步，包括安全性、准确性和患者治疗效果，正在鼓励医疗保健提供者投资新的呼吸支援设备。总之，呼吸系统疾病负担的增加正在推动市场成长。

“高端ICU人工呼吸器领域将占据全球人工呼吸器市场的最大份额。”

高级 ICU人工呼吸器占据全球人工呼吸器市场的最大份额，因为它们对于治疗加护病房中的危及生命的疾病至关重要。这种高阶设备具有全面且灵活的通气方式、先进的监测系统和完善的安全性能，是重症患者的必备设备。随着全球人口老化和呼吸系统疾病的流行，医疗机构渴望投资下一代 ICU 解决方案。此外，监管机构的持续发展和严格标准正在推动这些先进设备的使用，使其成为必须实现最大患者治疗效果的关键生命应用的完美选择。

“组合式人工呼吸器在人工呼吸器市场中占据最大的市场占有率。”

组合式人工呼吸器占据人工呼吸器领域最大的市场份额，因为它们提供了容量和压力控制市场占有率的最佳优势，使临床医生能够根据患者的个人需求量身定制呼吸支援。该产品可让临床医生精确控制通气量，同时限制压力以避免肺部创伤，从而为各种临床情况提供多功能解决方案。配对的高科技监控系统和自动调整不仅增加了便利性，而且还改善了患者的治疗效果。因此，加护病房对重症患者的动态灵活通气策略的需求很高，对联合人工呼吸器的需求也很大。此外，不断的技术创新、医疗设施支出的增加以及呼吸系统疾病数量的增加，都促使组合人工呼吸器占据了市场的主导地位。

“欧洲占据人工呼吸器市场第二大份额。”

欧洲是世界第二人工呼吸器市场，拥有完善的医疗基础设施、大量的政府投入和严格的法规，确保产品的最高品质。欧洲加护病房和医院覆盖率广，呼吸系统疾病发生率高，人工呼吸器老化严重，导致对有创和非侵入性人工呼吸器的需求不断增加。

此外，欧洲拥有一个充满活力的领先製造商社区，他们不断创新，推动着改善患者治疗效果的超现代技术的发展。前瞻性的医疗保健措施和全面的保险体系确保了欧洲在全球人工呼吸器市场中的强大市场地位和第二大市场占有率。

本报告对全球人工呼吸器市场进行了深入分析，包括关键驱动因素和限制因素、竞争格局和未来趋势。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

  • 人工呼吸器市场概况
  • 亚太地区人工呼吸器市场类型和国家（2024 年）
  • 人工呼吸器市场：地理成长机会
  • 人工呼吸器市场按地区划分
  • 人工呼吸器市场：已开发市场与新兴市场

第五章 市场概况

  • 介绍
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 任务
  • 产业趋势
    • 对高性能可携式人工呼吸器的需求不断增加
    • 市场整合
    • 多模态人工呼吸器需求不断成长
    • 非侵入性人工呼吸器的普及率不断提高
  • 技术分析
    • 关键技术
    • 互补技术
    • 相关技术
  • 定价分析
    • 主要企业人工呼吸器厂商参考价格
    • 各地区平均销售价格趋势
  • 价值链分析
  • 生态系分析
  • 供应链分析
  • 波特五力分析
  • 主要相关利益者和采购标准
  • 监管分析
    • 监管机构、政府机构和其他组织
    • 法规结构
  • 专利分析
  • 贸易分析
    • 人工呼吸器出口资料（HS 编码 9018）
    • 人工呼吸器进口资料（HS 编码 9018）
  • 重大会议和活动（2023-2024 年）
  • 赎回情况
  • 未满足的需求和最终用户的期望
  • 影响客户业务的趋势/干扰
  • 投资金筹措场景
  • 邻近市场分析
    • 呼吸诊断市场
    • 睡眠呼吸中止设备市场
  • 人工智慧/生成式人工智慧对人工呼吸器市场的影响
    • 介绍
    • 医学的未来—巨量资料和人工智慧
    • 通风管理知识系统

第六章人工呼吸器市场按类型

  • 介绍
  • 加护治疗人工呼吸器
  • 可携式/可携式人工呼吸器

第 7 章人工呼吸器市场按年龄划分

  • 介绍
  • 成人/儿童人工呼吸器
  • 新生儿/婴儿人工呼吸器

第 8 章 通风市场（依介面）

  • 介绍
  • 混合通气
  • 非侵入性通气
  • 侵入性通气

第 9 章人工呼吸器市场按类型

  • 介绍
  • 联合系统人工呼吸器
  • 容量人工呼吸器
  • 压力人工呼吸器
  • 其他人工呼吸器

第 10 章人工呼吸器市场（依护理环境划分）

  • 介绍
  • 医院和诊所
  • 门诊护理中心
  • 紧急医疗服务
  • 居家照护环境

第 11 章人工呼吸器市场（按地区）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 亚太宏观经济展望
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 其他亚太地区
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲国家
  • 中东和非洲
  • 海湾合作委员会国家

第十二章 竞争格局

  • 概述
  • 主要参与企业的策略/优势
  • 收益分析（2019-2023）
  • 市场占有率分析（2023 年）
  • 企业评估矩阵：主要企业（2023 年）
  • 公司评估矩阵：Start-Ups/中小企业（2023 年）
  • 人工呼吸器市场：研发支出
  • 公司估值和财务指标
  • 品牌/产品比较
  • 竞争场景

第十三章 公司简介

  • 主要企业
    • RESMED
    • GETINGE AB
    • KONINKLIJKE PHILIPS NV
    • DRAGERWERK AG & CO. KGAA
    • ICU MEDICAL INC.
    • ASAHI KASEI CORPORATION
    • AIR LIQUIDE
    • FLEXICARE (GROUP) LIMITED
    • NIHON KOHDEN CORPORATION
    • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • GE HEALTHCARE
    • BAXTER
    • VYAIRE MEDICAL, INC.
    • HAMILTON MEDICAL
  • 其他公司
    • SKANRAY TECHNOLOGIES, LTD.
    • AXCENT MEDICAL GMBH
    • METRAN CO., LTD.
    • MAGNAMED
    • LEISTUNG INGENIERIA SRL
    • AVASARALA TECHNOLOGIES LIMITED
    • AIRON CORPORATION
    • TRITON ELECTRONIC SYSTEMS LTD.
    • BIO-MED DEVICES, INC.
    • HEYER MEDICAL AG
    • AGVA HEALTHCARE
    • BIODESIGN INNOVATION LABS
    • NOCCARC ROBOTICS PVT LTD
    • UMBULIZER
    • SCHILLER HEALTHCARE INDIA PVT. LTD
    • AVI HEALTHCARE

第十四章 附录

Product Code: MD 4529

The ventilators market is projected to reach USD 4.66 Billion by 2029 from USD 3.71 Billion in 2024 at a CAGR of 4.7% during the forecast period.

Scope of the Report
Years Considered for the Study2021-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy Type, Age group, Interface, Mode, Care Setting and Region
Regions coveredNorth America, Europe, APAC, Latin America, Middle East & Africa, GCC Countries

Increscent respiratory illnesses like COPD and asthma are key drivers of the ventilators market. With growing air pollution levels, lifestyles, and ageing populations, an increased number of these chronic ailments have resulted in more frequent and severe respiratory attacks. COPD and severe asthma patients frequently need respiratory support through acute exacerbation, increasing hospital and homecare demand for both invasive and non-invasive ventilators. Further, ongoing advancements in ventilator technology-safety, accuracy, and patient outcomes-prompt healthcare professionals to invest in newer respiratory support equipment. In sum, the increasing burden of respiratory illnesses is driving market growth.

"The High-end ICU ventilators segment is accounted for the largest share of global ventilators market."

Premium ICU ventilators have the largest market share of the worldwide ventilators market due to the fact that they are essential in the treatment of life-threatening situations in intensive care units. Such high-end equipment has a comprehensive variety of ventilation modes, advanced monitoring systems, and improved safety features that are necessary for critical patients. With the aging worldwide population and prevalence of sophisticated respiratory diseases, healthcare facilities are aggressively investing in next-generation ICU solutions. In addition, ongoing development and strict standards imposed by regulative bodies support the use of these advanced devices, making them the go-to option in life-critical applications where the utmost patient outcomes must be achieved.

"Combined mode ventilation has the largest market share in ventilators market."

Combined mode ventilators command the highest market share in the ventilators segment due to the fact that they provide the most advantageous aspects of volume- and pressure-controlled ventilation, allowing clinicians to customize respiratory support to the individual needs of a patient. The products allow clinicians to accurately control tidal volumes while also limiting pressure so that the lungs are not injured, thereby giving a versatile solution that can work in a number of clinical circumstances. Their paired, high-tech monitoring systems and automated adjustments do not only add convenience but also improve patient results. Accordingly, combined mode ventilators are in great demand among intensive care units with critically ill patients who need dynamic and flexible modes of ventilation. In addition, unbroken technology innovation, increased spending on healthcare facilities, and increasing instances of respiratory diseases have each played a role to drive combined mode ventilators to the top of the market.

"Europe holds the second largest market share in the ventilators market."

Europe is the world's second-largest ventilator market, with its established healthcare infrastructure, heavy government spending, and stringent regulation that guarantees top-quality products. Extensive coverage of intensive care units and hospitals in Europe, combined with high incidence of respiratory conditions and the ageing population, all ensure rising demand for invasive as well as non-invasive ventilators.

Moreover, Europe is favored with a vibrant community of top-notch producers and never-ending innovation, leading to the development of ultra-modern technologies that improve patient results. Together with forward-looking healthcare measures and all-encompassing insurance coverage, Europe is a strong market for ventilators worldwide, guaranteeing its position as the second largest market share holder.

A breakdown of the primary participants (supply-side) for the ventilators market referred to for this report is provided below:

  • By Company Type: Tier 1-25%, Tier 2-40%, and Tier 3-35%
  • By Designation: C-level-20%, Director Level-38%, and Others-40%
  • By Region: North America-37%, Europe-28%, Asia Pacific-26%, Latin America- 6%, and Middle East and Africa- 1% and GCC Countries- 2%

Prominent players in this market include ResMed (US), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Dragerwerk AG & CO. KGAA (Germany), ICU Medical, Inc. (US), Asahi Kasei Corporation (Japan), Air Liquide (France), Flexicare (Group) Limited (UK), Nihon Kohden Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, (China), GE Healthcare (US), Baxter (US), Vyaire Medical, Inc. (US), Hamilton Medical (Switzerland), Skanray Technologies (India), aXcent Medical GmbH (Germany), Metran Co., Ltd (Japan), MAGNAMED (Brazil), Leistung Ingenieria SRL (Argentina), Avasarala Technologies Limited (India), Airon Corporation (Florida), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), HEYER Medical AG (Germany) and AgVa Healthcare (India).

Research Coverage:

The market study covers the ventilators market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, age group, interface, mode, care setting and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of Market Dynamics: Drivers (Rise in respiratory diseases

Urbanization and rising pollution levels, Rising obesity due to sedentary lifestyles, Growing geriatric population worldwide, Increasing preference for home care settings, Rising number of preterm births, Outbreak of infectious respiratory diseases) restraints (Shortage of skilled medical workers, Excessive purchase of ventilators during COVID-19, Reimbursement concerns) opportunities (Cost-efficiency of home care services, growth opportunities in emerging economies), and challenges (Low awareness and inadequate resources in emerging economies, Harmful effects of respiratory devices on neonates, Supply chain disruptions, Global demand fluctuations)

  • Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the ventilators market.
  • Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, care settings, and region.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the ventilators market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the ventilators market like ResMed (US), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Dragerwerk AG & CO. KGAA (Germany), and ICU Medical, Inc. (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED & REGIONS CONSIDERED
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES
  • 1.6 IMPACT OF AI/GEN AI

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS
    • 2.5.1 SCOPE-RELATED LIMITATIONS
    • 2.5.2 METHODOLOGY-RELATED LIMITATIONS
  • 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 VENTILATORS MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE AND COUNTRY (2024)
  • 4.3 VENTILATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 VENTILATORS MARKET: REGIONAL MIX
  • 4.5 VENTILATORS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rise in respiratory diseases
        • 5.2.1.1.1 Increasing incidences of COPD and asthma
        • 5.2.1.1.2 High prevalence of tobacco smoking
      • 5.2.1.2 Urbanization and rising pollution levels
      • 5.2.1.3 Rising obesity due to sedentary lifestyles
      • 5.2.1.4 Growing geriatric population worldwide
      • 5.2.1.5 Increasing preference for home care settings
      • 5.2.1.6 Rising number of preterm births
      • 5.2.1.7 Outbreak of infectious respiratory diseases
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Shortage of skilled medical workers
      • 5.2.2.2 Excessive purchase of ventilators during COVID-19
      • 5.2.2.3 Reimbursement concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Cost-efficiency of home care services
      • 5.2.3.2 Growth opportunities in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Low awareness and inadequate resources in emerging economies
      • 5.2.4.2 Harmful effects of respiratory devices on neonates
      • 5.2.4.3 Supply chain disruptions
      • 5.2.4.4 Global demand fluctuations
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 RISING DEMAND FOR ENHANCED PORTABLE VENTILATORS
    • 5.3.2 MARKET CONSOLIDATION
    • 5.3.3 GROWING DEMAND FOR MULTIMODAL VENTILATORS
    • 5.3.4 INCREASING ADOPTION OF NON-INVASIVE VENTILATORS
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 Sensor technologies
        • 5.4.1.1.1 Flow sensors
        • 5.4.1.1.2 Oxygen sensors
        • 5.4.1.1.3 Pressure sensors
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 E-nose technology
      • 5.4.2.2 MEMS technology
      • 5.4.2.3 Electrochemical technology
      • 5.4.2.4 Paramagnetic technology
      • 5.4.2.5 Wireless gas sensor technology
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 High-flow nasal cannula (HFNC) devices
  • 5.5 PRICING ANALYSIS
    • 5.5.1 INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER
    • 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 SUPPLY CHAIN ANALYSIS
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 THREAT OF NEW ENTRANTS
    • 5.9.2 THREAT OF SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF SUPPLIERS
    • 5.9.4 BARGAINING POWER OF BUYERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.10.2 BUYING CRITERIA
  • 5.11 REGULATORY ANALYSIS
    • 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.11.2 REGULATORY FRAMEWORK
      • 5.11.2.1 North America
        • 5.11.2.1.1 US
        • 5.11.2.1.2 Canada
      • 5.11.2.2 Europe
      • 5.11.2.3 Asia Pacific
        • 5.11.2.3.1 Japan
        • 5.11.2.3.2 China
        • 5.11.2.3.3 India
        • 5.11.2.3.4 South Korea
      • 5.11.2.4 Latin America
        • 5.11.2.4.1 Brazil
        • 5.11.2.4.2 Mexico
      • 5.11.2.5 Middle East
      • 5.11.2.6 Africa
  • 5.12 PATENT ANALYSIS
    • 5.12.1 PATENT PUBLICATION TRENDS FOR VENTILATORS
  • 5.13 TRADE ANALYSIS
    • 5.13.1 EXPORT DATA FOR VENTILATORS (HS CODE 9018)
    • 5.13.2 IMPORT DATA FOR VENTILATORS (HS CODE 9018)
  • 5.14 KEY CONFERENCES AND EVENTS, 2023-2024
  • 5.15 REIMBURSEMENT SCENARIO
  • 5.16 UNMET NEEDS AND END-USER EXPECTATIONS
    • 5.16.1 UNMET NEEDS IN VENTILATORS MARKET
    • 5.16.2 END-USER EXPECTATIONS IN VENTILATORS MARKET
  • 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.18 INVESTMENT & FUNDING SCENARIO
  • 5.19 ADJACENT MARKET ANALYSIS
    • 5.19.1 RESPIRATORY DIAGNOSTICS MARKET
    • 5.19.2 SLEEP APNEA DEVICES MARKET
  • 5.20 IMPACT OF AI/GEN AI ON VENTILATORS MARKET
    • 5.20.1 INTRODUCTION
    • 5.20.2 FUTURE OF HEALTHCARE-BIG DATA AND AI
    • 5.20.3 KNOWLEDGE-BASED SYSTEMS FOR VENTILATION MANAGEMENT

6 VENTILATORS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 INTENSIVE CARE VENTILATORS
    • 6.2.1 HIGH-END ICU VENTILATORS
      • 6.2.1.1 Rising healthcare expenditure and improving infrastructure in emerging economies to drive market
    • 6.2.2 MID-END ICU VENTILATORS
      • 6.2.2.1 Higher affordability and accessibility to drive market
    • 6.2.3 BASIC ICU VENTILATORS
      • 6.2.3.1 Growing use in ambulatory care centers to drive market
  • 6.3 PORTABLE/TRANSPORTABLE VENTILATORS
    • 6.3.1 INCREASING DEMAND FOR COMPACT DEVICES FOR MECHANICAL VENTILATION TO DRIVE MARKET

7 VENTILATORS MARKET, BY AGE GROUP

  • 7.1 INTRODUCTION
  • 7.2 ADULT & PEDIATRIC VENTILATORS
    • 7.2.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET
  • 7.3 NEONATAL/INFANT VENTILATORS
    • 7.3.1 TECHNOLOGICAL ADVANCEMENTS IN NEONATAL MONITORS TO DRIVE MARKET

8 VENTILATION MARKET, BY INTERFACE

  • 8.1 INTRODUCTION
  • 8.2 HYBRID VENTILATION
    • 8.2.1 RISING PREVALENCE OF COPD & ARDS TO DRIVE MARKET
  • 8.3 NON-INVASIVE VENTILATION
    • 8.3.1 RELIABILITY OF MECHANICAL DESIGNS TO DRIVE MARKET
  • 8.4 INVASIVE VENTILATION
    • 8.4.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET

9 VENTILATORS MARKET, BY MODE

  • 9.1 INTRODUCTION
  • 9.2 COMBINED-MODE VENTILATORS
    • 9.2.1 COMBINED BENEFITS OF VOLUME-TARGETED AND PRESSURE-TARGETED VENTILATORS TO DRIVE MARKET
  • 9.3 VOLUME-MODE VENTILATORS
    • 9.3.1 INCREASING DEMAND FOR ADVANCED RESPIRATORY SUPPORT SYSTEMS IN HEALTHCARE SETTINGS TO DRIVE MARKET
  • 9.4 PRESSURE-MODE VENTILATORS
    • 9.4.1 PRESET INSPIRATORY PRESSURE MAINTENANCE AND BETTER PATIENT COMFORT TO DRIVE MARKET
  • 9.5 OTHER VENTILATORS

10 VENTILATORS MARKET, BY CARE SETTING

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS & CLINICS
    • 10.2.1 RISING DEMAND FOR VENTILATORS IN PRIVATE HOSPITALS TO DRIVE MARKET
  • 10.3 AMBULATORY CARE CENTERS
    • 10.3.1 INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE MARKET
  • 10.4 EMERGENCY MEDICAL SERVICES
    • 10.4.1 HIGH INCIDENCE OF TRAUMA INJURIES TO DRIVE MARKET
  • 10.5 HOME CARE SETTINGS
    • 10.5.1 EMERGENCE OF REMOTE PATIENT MONITORING DEVICES TO DRIVE MARKET

11 VENTILATORS MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 High prevalence of COPD to drive the market
    • 11.2.3 CANADA
      • 11.2.3.1 Increasing incidence of asthma to drive market
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Rising healthcare spending to increase demand for high-end ventilators
    • 11.3.3 FRANCE
      • 11.3.3.1 Highly advanced healthcare system to drive adoption of ventilators in hospitals
    • 11.3.4 UK
      • 11.3.4.1 Increasing healthcare expenditure to drive market growth
    • 11.3.5 ITALY
      • 11.3.5.1 High growth in geriatric population and subsequent rise in age-related respiratory diseases to drive market
    • 11.3.6 SPAIN
      • 11.3.6.1 High burden on state-run health insurance system and poor healthcare infrastructure to restrain market growth
    • 11.3.7 NETHERLANDS
      • 11.3.7.1 Rising prevalence of respiratory diseases to drive market
    • 11.3.8 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 JAPAN
      • 11.4.2.1 Established healthcare system to increase adoption of respiratory care devices
    • 11.4.3 CHINA
      • 11.4.3.1 High prevalence of COPD and lung cancer to propel demand
    • 11.4.4 INDIA
      • 11.4.4.1 Rising focus of global players on the Indian market to drive adoption of advanced ventilators
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 High prevalence of chronic lung diseases to drive demand for ventilators
    • 11.4.6 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Healthcare infrastructure improvement to support market growth
    • 11.5.3 MEXICO
      • 11.5.3.1 Rising obesity rate to increase incidence rate of respiratory diseases
    • 11.5.4 ARGENTINA
      • 11.5.4.1 Incidence of severe acute respiratory infections to drive market
    • 11.5.5 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 RISING HEALTHCARE SPENDING AND PRESENCE OF MEDICAL DEVICE MANUFACTURING COMPANIES TO DRIVE MARKET
    • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.7 GCC COUNTRIES
    • 11.7.1 HIGHER DISPOSABLE INCOME AND INCREASED GOVERNMENT HEALTHCARE EXPENDITURE TO PROPEL MARKET GROWTH
    • 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 2023
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VENTILATORS MARKET
  • 12.3 REVENUE ANALYSIS, 2019-2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Region footprint
      • 12.5.5.3 Type footprint
      • 12.5.5.4 Age group footprint
      • 12.5.5.5 Interface footprint
      • 12.5.5.6 Mode footprint
      • 12.5.5.7 Care setting footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 12.6.5.1 Detailed list of key startups/SMEs
      • 12.6.5.2 Competitive benchmarking of key startups/SMEs
  • 12.7 VENTILATORS MARKET: R&D EXPENDITURE
  • 12.8 COMPANY VALUATION & FINANCIAL METRICS
    • 12.8.1 FINANCIAL METRICS
    • 12.8.2 COMPANY VALUATION
  • 12.9 BRAND/PRODUCT COMPARISON
  • 12.10 COMPETITIVE SCENARIO
    • 12.10.1 PRODUCT LAUNCHES & APPROVALS
    • 12.10.2 DEALS
    • 12.10.3 OTHER DEVELOPMENTS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 RESMED
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product launches & approvals
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Right to win
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses and competitive threats
    • 13.1.2 GETINGE AB
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Product launches & approvals
        • 13.1.2.3.2 Other developments
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Right to win
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses and competitive threats
    • 13.1.3 KONINKLIJKE PHILIPS N.V.
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Other developments
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Right to win
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses and competitive threats
    • 13.1.4 DRAGERWERK AG & CO. KGAA
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Product launches & approvals
        • 13.1.4.3.2 Deals
        • 13.1.4.3.3 Other developments
    • 13.1.5 ICU MEDICAL INC.
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Deals
    • 13.1.6 ASAHI KASEI CORPORATION
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Deals
    • 13.1.7 AIR LIQUIDE
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Deals
    • 13.1.8 FLEXICARE (GROUP) LIMITED
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Deals
    • 13.1.9 NIHON KOHDEN CORPORATION
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Product launches
    • 13.1.10 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products offered
    • 13.1.11 GE HEALTHCARE
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products offered
      • 13.1.11.3 Recent developments
        • 13.1.11.3.1 Deals
    • 13.1.12 BAXTER
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products offered
      • 13.1.12.3 Recent developments
        • 13.1.12.3.1 Deals
    • 13.1.13 VYAIRE MEDICAL, INC.
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products offered
      • 13.1.13.3 Recent developments
        • 13.1.13.3.1 Deals
        • 13.1.13.3.2 Other developments
    • 13.1.14 HAMILTON MEDICAL
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products offered
      • 13.1.14.3 Recent developments
        • 13.1.14.3.1 Product enhancements
  • 13.2 OTHER PLAYERS
    • 13.2.1 SKANRAY TECHNOLOGIES, LTD.
    • 13.2.2 AXCENT MEDICAL GMBH
    • 13.2.3 METRAN CO., LTD.
    • 13.2.4 MAGNAMED
    • 13.2.5 LEISTUNG INGENIERIA SRL
    • 13.2.6 AVASARALA TECHNOLOGIES LIMITED
    • 13.2.7 AIRON CORPORATION
    • 13.2.8 TRITON ELECTRONIC SYSTEMS LTD.
    • 13.2.9 BIO-MED DEVICES, INC.
    • 13.2.10 HEYER MEDICAL AG
    • 13.2.11 AGVA HEALTHCARE
    • 13.2.12 BIODESIGN INNOVATION LABS
    • 13.2.13 NOCCARC ROBOTICS PVT LTD
    • 13.2.14 UMBULIZER
    • 13.2.15 SCHILLER HEALTHCARE INDIA PVT. LTD
    • 13.2.16 AVI HEALTHCARE

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 RISK ASSESSMENT
  • TABLE 3 DISORDERS AND DEATHS CAUSED DUE TO SMOKING, 2024
  • TABLE 4 INDUSTRY TRENDS IN VENTILATORS MARKET
  • TABLE 5 INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER, 2024 (USD)
  • TABLE 6 AVERAGE SELLING PRICE TREND OF HIGH-END VENTILATORS, BY REGION, 2022-2024 (USD)
  • TABLE 7 VENTILATORS MARKET: ECOSYSTEM ANALYSIS
  • TABLE 8 VENTILATORS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 9 KEY STAKEHOLDERS IN BUYING PROCESS
  • TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS
  • TABLE 11 KEY BUYING CRITERIA FOR VENTILATORS
  • TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 LIST OF PATENTS IN VENTILATORS MARKET (2025)
  • TABLE 18 TRADE ANALYSIS OF MEDICAL DEVICE PRODUCTS, 2023 (USD MILLION)
  • TABLE 19 EXPORT DATA FOR VENTILATORS (HS CODE 9018), 2019-2023 (USD THOUSAND)
  • TABLE 20 IMPORT DATA FOR VENTILATORS (HS CODE 9018), 2019-2023 (USD THOUSAND)
  • TABLE 21 VENTILATORS MARKET: KEY CONFERENCES AND EVENTS, 2023-2024
  • TABLE 22 REIMBURSEMENT SCENARIO IN VENTILATORS MARKET
  • TABLE 23 UNMET NEEDS IN VENTILATORS MARKET
  • TABLE 24 END-USER EXPECTATIONS IN VENTILATORS MARKET
  • TABLE 25 VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 26 INTENSIVE CARE VENTILATORS: KEY PRODUCTS
  • TABLE 27 INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 28 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 29 INTENSIVE CARE VENTILATORS MARKET, BY REGION, 2021-2029 (THOUSAND UNITS)
  • TABLE 30 HIGH-END ICU VENTILATORS: KEY PRODUCTS
  • TABLE 31 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 32 HIGH-END ICU VENTILATORS MARKET, BY REGION, 2021-2029 (THOUSAND UNITS)
  • TABLE 33 MID-END ICU VENTILATORS: KEY PRODUCTS
  • TABLE 34 MID-END ICU VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 35 MID-END ICU VENTILATORS MARKET, BY REGION, 2021-2029 (THOUSAND UNITS)
  • TABLE 36 BASIC ICU VENTILATORS: KEY PRODUCTS
  • TABLE 37 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 38 BASIC ICU VENTILATORS MARKET, BY REGION, 2021-2029 (THOUSAND UNITS)
  • TABLE 39 PORTABLE/TRANSPORTABLE VENTILATORS: KEY PRODUCTS
  • TABLE 40 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 41 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY REGION, 2021-2029 (THOUSAND UNITS)
  • TABLE 42 VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 43 ADULT & PEDIATRIC VENTILATORS: KEY PRODUCTS
  • TABLE 44 ADULT & PEDIATRIC VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 45 NEONATAL/INFANT VENTILATORS: KEY PRODUCTS
  • TABLE 46 NEONATAL/INFANT VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 47 VENTILATION MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 48 HYBRID VENTILATION MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 49 NON-INVASIVE VENTILATION MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 50 INVASIVE VENTILATION MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 51 VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 52 COMBINED-MODE VENTILATORS: KEY PRODUCTS
  • TABLE 53 COMBINED-MODE VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 54 VOLUME-MODE VENTILATORS: KEY PRODUCTS
  • TABLE 55 VOLUME-MODE VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 56 PRESSURE-MODE VENTILATORS: KEY PRODUCTS
  • TABLE 57 PRESSURE-MODE VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 58 OTHER VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 59 VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 60 VENTILATORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 61 VENTILATORS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 62 VENTILATORS MARKET FOR EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 63 VENTILATORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 64 VENTILATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 70 NORTH AMERICA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 72 US: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 73 US: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 74 US: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 75 US: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 76 US: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 77 US: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 78 US: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 79 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020)
  • TABLE 80 CANADA: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 81 CANADA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 82 CANADA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 83 CANADA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 84 CANADA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 85 CANADA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 86 CANADA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 87 EUROPE: VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 88 EUROPE: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 89 EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 90 EUROPE: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 91 EUROPE: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 92 EUROPE: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 93 EUROPE: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 94 GERMANY: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 95 GERMANY: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 96 GERMANY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 97 GERMANY: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 98 GERMANY: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 99 GERMANY: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 100 GERMANY: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 101 FRANCE: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 102 FRANCE: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 103 FRANCE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 104 FRANCE: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 105 FRANCE: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 106 FRANCE: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 107 FRANCE: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 108 UK: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 109 UK: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 110 UK: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 111 UK: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 112 UK: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 113 UK: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 114 UK: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 115 ITALY: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 116 ITALY: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 117 ITALY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 118 ITALY: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 119 ITALY: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 120 ITALY: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 121 ITALY: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 122 SPAIN: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 123 SPAIN: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 124 SPAIN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 125 SPAIN: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 126 SPAIN: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 127 SPAIN: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 128 SPAIN: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 129 NETHERLANDS: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 130 NETHERLANDS: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 131 NETHERLANDS: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 132 NETHERLANDS: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 133 NETHERLANDS: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 134 NETHERLANDS: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 135 NETHERLANDS: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 136 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 137 REST OF EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 138 REST OF EUROPE: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 139 REST OF EUROPE: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 140 REST OF EUROPE: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 141 REST OF EUROPE: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 149 JAPAN: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 150 JAPAN: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 151 JAPAN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 152 JAPAN: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 153 JAPAN: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 154 JAPAN: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 155 JAPAN: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 156 CHINA: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 157 CHINA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 158 CHINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 159 CHINA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 160 CHINA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 161 CHINA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION).
  • TABLE 162 CHINA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 163 INDIA: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 164 INDIA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 165 INDIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 166 INDIA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 167 INDIA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 168 INDIA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 169 INDIA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 170 AUSTRALIA: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 171 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 172 AUSTRALIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 173 AUSTRALIA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 174 AUSTRALIA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 175 AUSTRALIA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 176 AUSTRALIA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 177 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 178 REST OF ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 179 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 180 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 181 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 182 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 183 LATIN AMERICA: VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
  • TABLE 184 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 185 LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 186 LATIN AMERICA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 187 LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 188 LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 189 LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 190 BRAZIL: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 191 BRAZIL: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 192 BRAZIL: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 193 BRAZIL: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 194 BRAZIL: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 195 BRAZIL: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 196 BRAZIL: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 197 MEXICO: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 198 MEXICO: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 199 MEXICO: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 200 MEXICO: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 201 MEXICO: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 202 MEXICO: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 203 MEXICO: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 204 ARGENTINA: KEY MACROINDICATORS FOR VENTILATORS MARKET
  • TABLE 205 ARGENTINA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 206 ARGENTINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 207 ARGENTINA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 208 ARGENTINA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 209 ARGENTINA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 210 ARGENTINA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 211 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 212 REST OF LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 213 REST OF LATIN AMERICA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 214 REST OF LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 215 REST OF LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 216 REST OF LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 221 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 222 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 223 GCC COUNTRIES: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 224 GCC COUNTRIES: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • TABLE 225 GCC COUNTRIES: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
  • TABLE 229 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VENTILATORS MARKET, 2021-2025
  • TABLE 230 VENTILATORS MARKET: DEGREE OF COMPETITION
  • TABLE 231 VENTILATORS MARKET: REGION FOOTPRINT
  • TABLE 232 VENTILATORS MARKET: TYPE FOOTPRINT
  • TABLE 233 VENTILATORS MARKET: AGE GROUP FOOTPRINT
  • TABLE 234 VENTILATORS MARKET: INTERFACE FOOTPRINT
  • TABLE 235 VENTILATORS MARKET: MODE FOOTPRINT
  • TABLE 236 VENTILATORS MARKET: CARE SETTING FOOTPRINT
  • TABLE 237 VENTILATORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 238 VENTILATORS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 239 VENTILATORS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 240 VENTILATORS MARKET: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 241 VENTILATORS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 242 RESMED: BUSINESS OVERVIEW
  • TABLE 243 RESMED: PRODUCTS OFFERED
  • TABLE 244 RESMED: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 245 GETINGE AB: BUSINESS OVERVIEW
  • TABLE 246 GETINGE AB: PRODUCTS OFFERED
  • TABLE 247 GETINGE AB: PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 248 GETINGE AB: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 249 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
  • TABLE 250 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 251 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 252 DRAGERWERK AG & CO. KGAA: BUSINESS OVERVIEW
  • TABLE 253 DRAGERWERK AG & CO. KGAA: PRODUCTS OFFERED
  • TABLE 254 DRAGERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 255 DRAGERWERK AG & CO. KGAA: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 256 DRAGERWERK AG & CO. KGAA: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 257 ICU MEDICAL INC.: BUSINESS OVERVIEW
  • TABLE 258 ICU MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 259 ICU MEDICAL, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 260 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
  • TABLE 261 ASAHI KASEI CORPORATION: PRODUCTS OFFERED
  • TABLE 262 ASAHI KASEI MEDICAL: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 263 AIR LIQUIDE: BUSINESS OVERVIEW
  • TABLE 264 AIR LIQUIDE: PRODUCTS OFFERED
  • TABLE 265 AIR LIQUIDE: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 266 FLEXICARE (GROUP) LIMITED: BUSINESS OVERVIEW
  • TABLE 267 FLEXICARE (GROUP) LIMITED: PRODUCTS OFFERED
  • TABLE 268 FLEXICARE (GROUP) LIMITED: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 269 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
  • TABLE 270 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
  • TABLE 271 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 272 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: BUSINESS OVERVIEW
  • TABLE 273 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
  • TABLE 274 GE HEALTHCARE: BUSINESS OVERVIEW
  • TABLE 275 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 276 GE HEALTHCARE: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 277 BAXTER: BUSINESS OVERVIEW
  • TABLE 278 BAXTER: PRODUCTS OFFERED
  • TABLE 279 BAXTER: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 280 VYAIRE MEDICAL, INC: BUSINESS OVERVIEW
  • TABLE 281 VYAIRE MEDICAL, INC: PRODUCTS OFFERED
  • TABLE 282 VYAIRE MEDICAL, INC: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 283 VYAIRE MEDICAL, INC: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 284 HAMILTON MEDICAL: BUSINESS OVERVIEW
  • TABLE 285 HAMILTON MEDICAL: PRODUCTS OFFERED
  • TABLE 286 HAMILTON MEDICAL: PRODUCT ENHANCEMENTS, JANUARY 2021-JANUARY 2025

List of Figures

  • FIGURE 1 VENTILATORS MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY CARE SETTING, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V. (NETHERLANDS) (2024)
  • FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION
  • FIGURE 10 DEMAND-SIDE MARKET SIZE ESTIMATION
  • FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR VENTILATORS MARKET (2024-2029)
  • FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 13 TOP-DOWN APPROACH
  • FIGURE 14 DATA TRIANGULATION METHODOLOGY
  • FIGURE 15 VENTILATORS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 VENTILATORS MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 VENTILATORS MARKET, BY INTERFACE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 VENTILATORS MARKET, BY MODE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 19 VENTILATORS MARKET, BY CARE SETTING, 2024 VS. 2029 (USD MILLION)
  • FIGURE 20 GEOGRAPHICAL SNAPSHOT OF VENTILATORS MARKET
  • FIGURE 21 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET
  • FIGURE 22 INTENSIVE CARE VENTILATORS SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2024
  • FIGURE 23 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 24 NORTH AMERICA WILL DOMINATE THE MARKET TILL 2029
  • FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES OVER FORECAST PERIOD
  • FIGURE 26 VENTILATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 27 ANNUAL DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE TYPE, 2024
  • FIGURE 28 GLOBAL GERIATRIC POPULATION, BY COUNTRY, 2015-2023
  • FIGURE 29 ACQUISITIONS IN VENTILATORS MARKET, JANUARY 2019-NOVEMBER 2023
  • FIGURE 30 AVERAGE SELLING PRICE TREND FOR HIGH-END VENTILATORS, BY REGION, 2022-2024 (USD)
  • FIGURE 31 VENTILATORS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 32 VENTILATORS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 33 SUPPLY CHAIN ANALYSIS
  • FIGURE 34 VENTILATORS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS
  • FIGURE 36 KEY BUYING CRITERIA FOR VENTILATORS
  • FIGURE 37 TOP PATENT APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS), JANUARY 2015-FEBRUARY 2025
  • FIGURE 38 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 39 NUMBER OF DEALS AND FUNDING IN VENTILATORS MARKET, 2019-2023 (USD MILLION)
  • FIGURE 40 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
  • FIGURE 41 VALUE OF INVESTOR DEALS, BY KEY PLAYERS, 2019-2023 (USD MILLION)
  • FIGURE 42 RESPIRATORY DIAGNOSTICS MARKET OVERVIEW
  • FIGURE 43 SLEEP APNEA DEVICES MARKET OVERVIEW
  • FIGURE 44 AI INTEGRATION FOR VENTILATORS
  • FIGURE 45 IMPACT OF AI/GEN AI ON VENTILATORS MARKET
  • FIGURE 46 NORTH AMERICA: VENTILATORS MARKET SNAPSHOT
  • FIGURE 47 ASIA PACIFIC: VENTILATORS MARKET SNAPSHOT
  • FIGURE 48 REVENUE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET (2019-2023)
  • FIGURE 49 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET (2023)
  • FIGURE 50 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 51 VENTILATORS MARKET: COMPANY FOOTPRINT
  • FIGURE 52 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 53 R&D EXPENDITURE OF KEY PLAYERS IN VENTILATORS MARKET (2022 VS. 2023)
  • FIGURE 54 EV/EBITDA OF KEY VENDORS
  • FIGURE 55 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 56 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 57 RESMED: COMPANY SNAPSHOT (2023)
  • FIGURE 58 GETINGE AB: COMPANY SNAPSHOT (2023)
  • FIGURE 59 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
  • FIGURE 60 DRAGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 61 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 62 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 63 AIR LIQUIDE: COMPANY SNAPSHOT (2023)
  • FIGURE 64 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 65 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 66 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 67 BAXTER: COMPANY SNAPSHOT (2023)